At the news
? NEUTRALIMPACT 4/10 DEFA14A filed Apr 3, 2026 at 16:05 ET
CVS Health is holding its 2026 annual shareholder meeting to vote on director elections, auditor ratification, executive compensation, and a shareholder proposal to lower the threshold for shareholder action by written consent. This filing follows the recent addition of John Gallina to the board, indicating continuity in governance.
- Annual meeting scheduled for May 14, 2026, to vote on 13 director nominees, auditor ratification, executive compensation (Say on Pay), and a new incentive plan.
- Shareholders are asked to vote against a proposal to reduce the threshold for shareholder action by written consent.
- Recent 8-K filing confirms John Gallina's election to the board on March 19, 2026, as an independent director and member of the Audit Committee.
- The filing is a standard annual proxy statement with no major governance changes or contentious issues.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access